Drawn to Science: Target identification in drug discovery

Автор: Roche

Загружено: 2013-09-06

Просмотров: 53807

Описание: Identifying the biological origin of a disease, and the potential targets for intervention, is the first step in the discovery of a medicine. More an art than a science, target identification is grounded in a number of different approaches and technologies, many of which are used in Roche "Pharma Research and Early Development" (Roche pRED). For more information visit www.roche.com.

More videos on / roche

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...

Drawn to Science: Target identification in drug discovery

Доступные форматы для скачивания:

Скачать видео

Информация по загрузке:

Скачать аудио

Похожие видео

Drawn to Science | Biomarkers in drug discovery

Drawn to Science | Biomarkers in drug discovery

Roche Pharma Research and Early Development (pRED) at a glance

Roche Pharma Research and Early Development (pRED) at a glance

Prof. Krzysztof Krawiec, Neurosymbolic Architectures: Analysis and Interpretation of Medical Imaging

Prof. Krzysztof Krawiec, Neurosymbolic Architectures: Analysis and Interpretation of Medical Imaging

Clinical Pharmacology: the right dose for every patient

Clinical Pharmacology: the right dose for every patient

From idea to medicine | Drug development at Roche

From idea to medicine | Drug development at Roche

Европа остарява. Готови ли сме?

Европа остарява. Готови ли сме?

Drawn to Science | Clinical trials

Drawn to Science | Clinical trials

PD-L1/PD-1 pathway: a security checkpoint

PD-L1/PD-1 pathway: a security checkpoint

Drawn to Science: Zebrafish - a new model for drug discovery

Drawn to Science: Zebrafish - a new model for drug discovery

Drawn to Science: Innovative clinical trial design

Drawn to Science: Innovative clinical trial design

Voces para la Salud: Segundo capítulo con Daniela Sugg

Voces para la Salud: Segundo capítulo con Daniela Sugg

Unleashing the T-cell army | Cancer immunotherapy at Roche

Unleashing the T-cell army | Cancer immunotherapy at Roche

Dr. Stephen Pfohl - Understanding bias in health AI

Dr. Stephen Pfohl - Understanding bias in health AI

The benefits of using Pharmacokinetic and Pharmacodynamic modeling

The benefits of using Pharmacokinetic and Pharmacodynamic modeling

Diario de Amelia en Chile: Capítulo 1

Diario de Amelia en Chile: Capítulo 1

Drawn to Science: The glycosylation of antibodies

Drawn to Science: The glycosylation of antibodies

SMA Challenges: Winning Solutions from Slovenia, Croatia, and Silicon Valley!

SMA Challenges: Winning Solutions from Slovenia, Croatia, and Silicon Valley!

Dr Judy Wawira Gichoya - Shortcut learning in medical imaging

Dr Judy Wawira Gichoya - Shortcut learning in medical imaging

The benefits of using modeling and simulation in drug development

The benefits of using modeling and simulation in drug development

Drawn to Science | T-cell bispecific antibodies

Drawn to Science | T-cell bispecific antibodies